New treatments for meth addiction could be near; CRISPR treatment safely corrects DNA of six patients with rare disease

Monoclonal antibodies are one of several promising new approaches to battling a type of addiction that had defied medication treatment. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

The meth crisis is worse than ever, but new treatments might be around the corner By Lev Facher Adobe Monoclonal antibodies are one of several promising new approaches to battling a type of addiction that had defied medication treatment. Read More STAT+: Intellia says CRISPR treatment safely corrects DNA of six patients with rare disease By Megan Molteni Ruby Wallau for STAT The company said patients with a genetic swelling disorder had small, corrective changes made to dysfunctional DNA inside their liver cells. Read More STAT+: Savvier buyers threaten mental health tech's momentum By Mario Aguilar Stephan Melzer/Alamy Early in the pandemic, employers panic-shopped for virtual mental health services. Now, there are signs of that sales momentum slowing down. Read More Sponsor content by STAT Events Leading JAMA Through Turmoil New JAMA editor-in-chief, health equity advocate Kirsten Bibbins-Domingo, takes the virtual stage on September 20. She'll share how she plans to steer the prestigious publication through recent turbulence and chart a new journey forward. Join the conversation. At a fashion show for people with spinal muscular atrophy, models take back their own stories By Matthew Herper Courtesy IMAXTree for Genentech The event was part of an initiative to raise awareness about the lives and needs of people with spinal muscular atrophy. Read More STAT+: Humana appeases Wall Street with big projections of Medicare Advantage growth By Bob Herman Richard Drew/AP During an investor day, Humana worked to appease Wall Street’s concerns that it was losing ground in the booming Medicare Advantage market. Read More Opinion: The White House has a major chance to improve coordination of federal nutrition efforts By Stephanie Rogus and Peter G. Lurie Adobe Federal nutrition research is not coordinated, and there's no official accounting of its funding. The White House can change that. Read More Friday, September 16, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser